Wuxi Kaiyi Hospital
无锡凯宜医院
About the Hospital
Wuxi Kaiyi Hospital is the first foreign-invested comprehensive hospital in Wuxi, invested and constructed by Columbia China Medical Group with a total investment of US$120 million. Established in 2017, it is the first newly built Grade 2 general hospital by Columbia China in China. As a designated medical insurance hospital in Wuxi, the hospital undertakes comprehensive service functions including medical care, health management, and rehabilitation, holding a benchmark position in Wuxi's high-end medical market. The hospital is committed to patient-centered service philosophy, introducing a private medical service system synchronized with the United States to eliminate cross-border medical difficulties and achieve truly zero-difference healthcare. The hospital covers a total area of approximately 44,380 square meters with 200 approved beds, 9 operating rooms, and 10 ICU beds, equipped with advanced medical equipment including MRI, CT, DSA, and an IoT smart ward system. Clinical departments are comprehensive, covering Internal Medicine (Cardiovascular, Respiratory, Gastroenterology, Nephrology, Endocrinology), Surgery (General, Urology, Orthopedics), Obstetrics and Pediatrics, Brain Disease Center, Dialysis Center, Health Management Center, TCM Department, Rehabilitation Department, Dentistry, Medical Aesthetics, and Ophthalmology-ENT, staffed with professional international medical experts and nursing personnel. The VIP Center is a distinctive feature, offering an exclusive consultation area for expatriates with independent clinic operations, multilingual one-on-one accompanying services, translation and interpretation, full accompaniment, and online consultation. The hospital has established direct billing cooperation with over 20 insurance companies, providing bilingual services including English examination reports and medical certificates. As a pioneer in IoT hospital construction and the first foreign-invested comprehensive hospital in Wuxi, the hospital fills a significant gap in Wuxi's foreign-invested medical market.